Best Practices from the American Society of Pain and Neuroscience (ASPN) for Clinical Research During a Pandemic or Emergency

References

• Anderson A, Borfitz D, Getz K. Global public attitudes about clinical research and patient experiences with clinical trials. JAMA Netw Open. 2018;1(6):e182969. doi:10.1001/jamanetworkopen.2018.2969
   PubMed Web of Science ®Google Scholar
• Fidelity Charitable. The role of volunteering in philanthropy. Available from: https://www.fidelitycharitable.org/insights/the-role-of-volunteering-in-philanthropy.html. Accessed April 8, 2021.
   Google Scholar
• Shiely F, Foley J, Stone A, et al. Managing clinical trials during COVID-19: experience from a clinical research facility. Trials. 2021;22(1):62. doi:10.1186/s13063-020-05004-8
   PubMed Web of Science ®Google Scholar
• Eshraghi Y, Chakravarthy K, Strand NH, et al. The American Society of Pain and Neuroscience (ASPN) practical guidelines to study design and scientific manuscript preparation in neuromodulation. JPR. 2021;14:1027–1041. doi:10.2147/JPR.S295502
   Google Scholar
• World Health Organization. Recommended format for a “research protocol”. Available from: https://www.who.int/groups/global-network-of-who-collaborating-centres-for-bioethics/about/research-ethics-review-committee. Accessed February 15, 2021.
   Google Scholar
• Children’s Hospital of Philadelphia Research Institute. Writing a protocol. Available from: https://irb.research.chop.edu/writing-protocol. Accessed February 15, 2021.
   Google Scholar
• Chan A-W, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–207. doi:10.7326/0003-4819-158-3-201302050-00583
   PubMed Web of Science ®Google Scholar
• Rosa C, Campbell A, Kleppinger C, Sampson R, Tyson C, Mamay-Gentilin S. Quality assurance of research protocols conducted in the community: the National Institute on Drug Abuse Clinical Trials Network experience. Clin Trials. 2009;6(2):151–161. doi:10.1177/1740774509102560
   Web of Science ®Google Scholar
• World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Am Med Assoc. 2013;310(20):2161–2194. doi:10.1001/jama.2013.281053
   Web of Science ®Google Scholar
• IDE Institutional Review Boards (IRB). U.S. Food and Drug Administration; 2019. Available from: https://www.fda.gov/medical-devices/investigational-device-exemption-ide/ide-institutional-review-boards-irb. Accessed February 15, 2021.
   Google Scholar
• Kim WO. Institutional review board (IRB) and ethical issues in clinical research. Korean J Anesthesiol. 2012;62(1):3–12. doi:10.4097/kjae.2012.62.1.3
   PubMedGoogle Scholar
• Baquet CR, Henderson K, Commiskey P, Morrow JN. Clinical trials – the art of enrollment. Semin Oncol Nurs. 2008;24(4):262–269. doi:10.1016/j.soncn.2008.08.006
   PubMedGoogle Scholar
• Guideline for good clinical practice - ICH harmonised tripartite guideline; 2002. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e6-r1-guideline-good-clinical-practice_en.pdf. Accessed February 15, 2021.
   Google Scholar
• International Organization for Standardization. ISO 14155:2011 - Clinical investigation of medical devices for human subjects — good clinical practice. ISO 14155: Available from: https://www.iso.org/standard/45557.html. Accessed January 20, 2023.
   Google Scholar
• Directive 2010/63/EU of the European Parliament and of the Council of 22  September 2010 on the protection of animals used for scientific purposes text with EEA relevance. Vol OJ L.; 2010. Available from: http://data.europa.eu/eli/dir/2010/63/oj/eng. Accessed February 15, 2021.
   Google Scholar
• Mahalmani VM, Mahendru D, Semwal A, et al. COVID-19 pandemic: a review based on current evidence. Indian J Pharmacol. 2020;52(2):117–129. doi:10.4103/ijp.IJP_310_20
   Web of Science ®Google Scholar
• van Dorn A. COVID-19 and readjusting clinical trials. Lancet. 2020;396(10250):523–524. doi:10.1016/S0140-6736(20)31787-6
   PubMed Web of Science ®Google Scholar
• Deer TR, Sayed D, Pope JE, et al. Emergence from the COVID-19 pandemic and the care of chronic pain: guidance for the interventionalist. Anesth Analg. 2020;131(2):387–394. doi:10.1213/ANE.0000000000005000
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Conduct of clinical trials of medical products during the COVID-19 public health emergency guidance for industry, investigators, and institutional review boards; 2021. Available from: https://www.fda.gov/media/136238/download. Accessed March 18, 2021.
   Google Scholar
• Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The impact of the COVID-19 pandemic on cancer care. Nat Cancer. 2020;1(6):565–567. doi:10.1038/s43018-020-0074-y
   PubMedGoogle Scholar
• Daugherty EL, White DB. Conducting clinical research during disasters. AMA J Ethics. 2010;12(9):701–705. doi:10.1001/virtualmentor.2010.12.9.ccas1-1009
   Google Scholar
• The Belmont report: ethical principles and guidelines for the protection of human subjects of research; 1979. Available from: https://www.hhs.gov/ohrp/sites/default/files/the-belmont-report-508c_FINAL.pdf. Accessed January 20, 2021.
   Google Scholar
• 45 CFR 46: protection of human subjects; 2009. Available from: https://www.govinfo.gov/content/pkg/CFR-2016-title45-vol1/pdf/CFR-2016-title45-vol1-part46.pdf. Accessed April 8, 2021.
   Google Scholar
• Beauchamp TL, Childress JF. Principles of Biomedical Ethics. Oxford University Press; 2013.
   Google Scholar
• Casarett DJ, Karlawish J. Beyond informed consent: the ethical design of pain research. Pain Med. 2001;2(2):138–146. doi:10.1046/j.1526-4637.2001.002002138.x
   Web of Science ®Google Scholar
• Emanuel EJ, Grady CC, Crouch RA, Lie RK, Miller FG, Wendler DD. The Oxford Textbook of Clinical Research Ethics. Oxford University Press; 2011.
   Google Scholar
• Coleman BC, Kean J, Brandt CA, Peduzzi P, Kerns RD. Adapting to disruption of research during the COVID-19 pandemic while testing nonpharmacological approaches to pain management. Transl Behav Med. 2020;10(4):827–834. doi:10.1093/tbm/ibaa074
   PubMed Web of Science ®Google Scholar
• National Institute for Health Research. DHSC issues guidance on the impact of COVID-19 on research funded or supported by NIHR; 2020. Available from: https://www.nihr.ac.uk/news/dhsc-issues-guidance-on-The-impact-on-covid-19-on-research-funded-or-supported-by-nihr/24469. Accessed January 2, 2020.
   Google Scholar
• Chan DX, Lin XF, George JM, Liu CW. Clinical challenges and considerations in management of chronic pain patients during a COVID-19 pandemic. Ann Acad Med Singap. 2020;49(9):669–673. doi:10.47102/annals-acadmedsg.2020130
   Web of Science ®Google Scholar
• Fluery ME, Farner AM, Unger JM. Association of the COVID-19 outbreak with patient willingness to enroll in cancer clinical trials. JAMA Oncol. 2020;7(1):131–132. doi:10.1001/jamaoncol.2020.5748
   Web of Science ®Google Scholar
• The impact of COVID-19 on clinical trial sites: the results of a global survey performed by Medidata; 2020. Available from: https://www.medidata.com/wp-content/uploads/2020/05/COVID19-Site-Survey_20200518_v1.pdf. Accessed May 31, 2020.
   Google Scholar
• Medicines and Healthcare products Regulatory Agency. Managing clinical trials during Coronavirus (COVID-19). Available from: https://www.gov.uk/guidance/managing-clinical-trials-during-coronavirus-covid-19. Accessed January 20, 2023.; 2020.
   Google Scholar
• Tait RC. Vulnerability in clinical research with patients in pain: a risk analysis. J Law Med Ethics. 2009;37(1):59–72. doi:10.1111/j.1748-720X.2009.00351.x
   Web of Science ®Google Scholar
• Schatman ME, Wegrzyn EL. The United States Drug Enforcement Administration and prescription opioid production quotas: an end game of eradication? J Pain Res. 2020;13:2629–2631. doi:10.2147/JPR.S285835
   Web of Science ®Google Scholar
• Kipnis K. Vulnerability in research subjects: a bioethical taxonomy; 2021. Available from: https://aapcho.org/wp/wp-content/uploads/2012/02/Kipnis-VulnerabilityinResearchSubjects.pdf. Accessed February 19, 2021.
   Google Scholar
• Shapiro H, Kulich RJ, Schatman ME. Manifestation of borderline personality symptomatology in chronic pain patients under stress: an understated and exacerbated consequence of the COVID-19 crisis. J Pain Res. 2020;13:1431–1439. doi:10.2147/JPR.S264761
   PubMed Web of Science ®Google Scholar
• Fleming TR, Labriola D, Wittes J. Conducting clinical research during the COVID-19 pandemic: protecting scientific integrity. JAMA. 2020;324(1):33. doi:10.1001/jama.2020.9286
   PubMed Web of Science ®Google Scholar
• Bauchner H, Fontanarosa PB. Randomized clinical trials and COVID-19: managing expectations. JAMA. 2020;323(22):2262. doi:10.1001/jama.2020.8115
   PubMed Web of Science ®Google Scholar
• McDermott MM, Newman AB. Preserving clinical trial integrity during the coronavirus pandemic. JAMA. 2020;323(21):2135. doi:10.1001/jama.2020.4689
   PubMed Web of Science ®Google Scholar
• Fleming TR. Addressing missing data in clinical trials. Ann Intern Med. 2011;154(2):113. doi:10.7326/0003-4819-154-2-201101180-00010
   Web of Science ®Google Scholar
• European Medicines Agency. Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic; 2020. Available from: https://www.ema.europa.eu/en/news/guidance-sponsors-how-manage-clinical-trials-during-covid-19-pandemic. Accessed January 20, 2023.
   Google Scholar
• Brosteanu O, Houben P, Ihrig K, et al. Risk analysis and risk adapted on-site monitoring in noncommercial clinical trials. Clin Trials. 2009;6(6):585–596. doi:10.1177/1740774509347398
   Web of Science ®Google Scholar
• Restart framework; 2020. Available from: https://www.nihr.ac.uk/documents/restart-framework/24886. Accessed January 20, 2023.
   Google Scholar
• Guideline on missing data in confirmatory clinical trials; 2010. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-missing-data-confirmatory-clinical-trials_en.pdf. Accessed January 20, 2023.
   Google Scholar
• Mitchell EJ, Ahmed K, Breeman S, et al. It is unprecedented: trial management during the COVID-19 pandemic and beyond. Trials. 2020;21(1):784. doi:10.1186/s13063-020-04711-6
   PubMed Web of Science ®Google Scholar
• Nature Medicine. Safeguard research in the time of COVID-19. Nat Med. 2020;26(443). doi:10.1038/s41591-020-0852-1
   Google Scholar